1. The Dutch Working Party on Antibiotic Policy (SWAB) Recommendations for the Diagnosis and Management of Febrile Neutropenia in Patients with Cancer

   • J. R. de la Court
   • A. H. W. Bruns
   • J. Heijmans

   Guidelines Open access 14 October 2022 Pages: 2063 - 2098

   

2. Performance Evaluation of the Microfluidic Antigen LumiraDx SARS-CoV-2 and Flu A/B Test in Diagnosing COVID-19 and Influenza in Patients with Respiratory Symptoms

   • Jayne E. Ellis
   • Poppy Guest
   • Andrew McCulloch

   Original Research Open access 24 September 2022 Pages: 2099 - 2109

   

3. Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study

   • Lorena De La Mora
   • María J. Nebot
   • Josep Mallolas

   Original Research Open access 29 September 2022 Pages: 2111 - 2124

   

4. Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19

   • Jessica J. Jalbert
   • Mohamed Hussein
   • Wenhui Wei

   Original Research Open access 01 October 2022 Pages: 2125 - 2139

   

5. PCV13 Pediatric Routine Schedule Completion and Adherence Before and During the COVID-19 Pandemic in the United States

   • Liping Huang
   • Jennifer L. Nguyen
   • Adriano Arguedas

   Original Research Open access 10 October 2022 Pages: 2141 - 2158

   

6. Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial

   • Maria J. G. T. Vehreschild
   • Petar Atanasov
   • Andreas R. Muehler

   Original Research Open access 15 October 2022 Pages: 2159 - 2176

   

7. Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study—The ARTHR-IS Study Group

   • Reinaldo Espíndola
   • Venanzio Vella
   • The ARTHR-IS Group

   Original Research Open access 15 October 2022 Pages: 2177 - 2203

   

8. Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial

   • Sanjeev Sinha
   • Anuj Ajayababu
   • Ravindra Mohan Pandey

   Original Research Open access 15 October 2022 Pages: 2205 - 2217

   

9. Incidence, Clinical Features, and Association with Prognosis of Bloodstream Infection in Pediatric Patients After Percutaneous or Surgical Treatment for Ventricular Septal Defect or Atrial Septal Defect: A Retrospective Cohort Study

   • Qinchang Chen
   • Jinjin Yu
   • Shushui Wang

   Original Research Open access 15 October 2022 Pages: 2219 - 2232

   

10. Follow-Up of Newborns with Hepatitis B Antigenemia

    • Jing Qi
    • Huijuan Liu
    • Pan Zhao

    Original Research Open access 25 October 2022 Pages: 2233 - 2240

    

11. Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir

    • Yayun Liu
    • Lingling Ge
    • Xuesong Liang

    Original Research Open access 30 October 2022 Pages: 2241 - 2251

    

12. International Validation of a Methicillin-Resistant Staphylococcus aureus Risk Assessment Tool for Skin and Soft Tissue Infections

    • E. J. Zasowski
    • T. D. Trinh
    • Michael J. Rybak

    Original Research Open access 01 November 2022 Pages: 2253 - 2263

    

13. Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials

    • Desmond Curran
    • Sean Matthews
    • Kenneth Schmader

    Original Research Open access 02 November 2022 Pages: 2265 - 2277

    

14. Excess of Post-Acute Sequelae of COVID-19 After the First Wave of the Pandemic

    • Marc Scherlinger
    • Cédric Lemogne
    • Jean Sibilia

    Brief Report Open access 26 September 2022 Pages: 2279 - 2285

    

15. Exploring the Role of Antiviral Nasal Sprays in the Control of Emerging Respiratory Infections in the Community

    • Christoforos Hadjichrysanthou
    • Anna L. Beukenhorst
    • Frank de Wolf

    Brief Report Open access 30 October 2022 Pages: 2287 - 2296

    

16. Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants

    • Caroline Perry
    • Mohammad Hossain
    • Salim Janmohamed

    Study Protocol Open access 21 October 2022 Pages: 2297 - 2310

    

17. Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports

    • Xiao-Shan Zhang
    • Yu-Zhen Wang
    • Cong-Rong Tang

    Case Report Open access 08 April 2022 Pages: 2311 - 2319

    

18. Correction to: Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports

    • Xiao-Shan Zhang
    • Yu-Zhen Wang
    • Cong-Rong Tang

    Correction Open access 05 November 2022 Pages: 2321 - 2321